| DBV TECHNOLOGIES EO -,10 |
| Frankreich |
| Gesundheit |
| FR0010417345 / A1JWB7 |
| DBV (Frankfurt) |
| FRA:DBV, ETR:DBV, DBV:GR |
| - |
| https://dbv-technologies... |
|
DBV Technologies SA is a clinical-stage French biopharmaceutical company headquartered in Bagneux, specializing in immunotherapy for food allergies. It pioneers the Viaskin technology, an epicutaneous patch that delivers allergens like peanut or milk..
>Volltext.. |
| 1001.81 Mio. EUR |
| 855.44 Mio. EUR |
| - |
| -118.39 Mio. EUR |
| -129.01 Mio. EUR |
| -0.93 EUR |
| 18.38 Mio. EUR |
| 164.62 Mio. EUR |
| -106.91 Mio. EUR |
| 3.35 |
| - |
| -23.11% |
| - |
| - |
| - |
| - |
| DBV TECHNOLOGIES, DBV TECH |
| 16.04.26 |